Target
Tyrosine-protein kinase JAK2 [831-1132]
Ligand
BDBM50503287
Substrate
n/a
Meas. Tech.
Enzyme Inhibition Assay
IC50
64.0±n/a nM
Citation
 Nilsson, KMAstrand, ABBerggren, AIJohansson, JRLepisto, MJKawatkar, SPSu, QKettle, JG JAK1 selective inhibitors US Patent  US10961228 Publication Date 3/30/2021 
Target
Name:
Tyrosine-protein kinase JAK2 [831-1132]
Synonyms:
JAK2 | JAK2 (aa 831-1132) | JAK2_HUMAN | Tyrosine-protein kinase JAK2 (aa 831-1132)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
35337.99
Organism:
Homo sapiens (Human)
Description:
O60674[831-1132]
Residue:
302
Sequence:
GFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
  
Inhibitor
Name:
BDBM50503287
Synonyms:
ABT-494 | Rinvoq | US10961228, Example ABT-494 | Upadacitinib
Type:
Small organic molecule
Emp. Form.:
C17H19F3N6O
Mol. Mass.:
380.3676
SMILES:
CC[C@@H]1CN(C[C@@H]1c1cnc2cnc3[nH]ccc3n12)C(=O)NCC(F)(F)F |r|
Structure:
Search PDB for entries with ligand similarity: